Literature DB >> 23730666

Bullous fixed drug eruption to ciprofloxacin: a case report.

Sonia Pramod Jain1, Pramod Ajit Jain.   

Abstract

Adverse reactions to medications are extremely common and display a characteristic clinical morphology such as fixed drug eruption (FDE), Stevens-Johnson syndrome, urticaria, morbilliform exanthem, hypersensitivity syndrome, pigmentary changes, lichenoid, dermatitis, acute generalized exanthematous pustulosis, photosensitivity, vasculitis etc. Here we report a case of a 60 year old male who presented to us with multiple bullous eruptions over both the hands and feet after oral ingestion of ciprofloxacin.

Entities:  

Keywords:  Ciprofloxacin; Drug reaction

Year:  2013        PMID: 23730666      PMCID: PMC3644464          DOI: 10.7860/JCDR/2013/4757.2901

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

1.  Ciprofloxacin-induced bullous fixed drug eruption.

Authors:  S K Bose
Journal:  Indian J Dermatol Venereol Leprol       Date:  1995 Jul-Aug       Impact factor: 2.545

2.  Psoriasiform fixed drug eruption caused by nimesulide.

Authors:  A C Katoulis; E Bozi; A Kanelleas; M Makris; A Alevizou; I Panagiotides; N G Stavrianeas
Journal:  Clin Exp Dermatol       Date:  2009-05-26       Impact factor: 3.470

3.  Ciprofloxacin-induced generalized bullous fixed drug eruption.

Authors:  Simin Ada; Sema Yilmaz
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 Sep-Oct       Impact factor: 2.545

4.  Fluoroquinolone-induced generalized fixed drug eruption.

Authors:  Jonathan L Hager; Mohsin R Mir; Sylvia Hsu
Journal:  Dermatol Online J       Date:  2009-12-15

5.  Fixed drug eruption induced by ciprofloxacin followed by ofloxacin.

Authors:  A Kawada; M Hiruma; K Morimoto; A Ishibashi; H Banba
Journal:  Contact Dermatitis       Date:  1994-09       Impact factor: 6.600

6.  Drug related clinical pattern in fixed drug eruption.

Authors:  E Ozkaya-Bayazit; H Bayazit; G Ozarmagan
Journal:  Eur J Dermatol       Date:  2000-06       Impact factor: 3.328

Review 7.  Drug-related problems in hospitals: a review of the recent literature.

Authors:  Anita Krähenbühl-Melcher; Raymond Schlienger; Markus Lampert; Manuel Haschke; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 8.  Quinolone hypersensitivity.

Authors:  Paolo Campi; Werner J Pichler
Journal:  Curr Opin Allergy Clin Immunol       Date:  2003-08

9.  Vulvar fixed drug eruption. A report of 13 cases.

Authors:  Gayle Fischer
Journal:  J Reprod Med       Date:  2007-02       Impact factor: 0.142

10.  A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.

Authors:  L V Wilton; G L Pearce; R D Mann
Journal:  Br J Clin Pharmacol       Date:  1996-04       Impact factor: 4.335

View more
  5 in total

1.  Extensive Fixed Drug Eruption Due to Diclofenac.

Authors:  Rudrajit Paul; Gautam Lahiri; Tanmay J Sau; Kunal Haldar; Rajesh Pandey; Asim Saha
Journal:  Sultan Qaboos Univ Med J       Date:  2017-03-30

Review 2.  A case of entecavir-associated bullous fixed drug eruption and a review of literature.

Authors:  Selami Aykut Temiz; İlkay Özer; Arzu Ataseven; Sıddıka Fındık
Journal:  Turk J Gastroenterol       Date:  2019-03       Impact factor: 1.852

3.  A Case of Self-treatment Induced Recurrent Fixed Drug Eruptions Associated with the Use of Different Fixed Dose Combinations of Fluoroquinolone-Nitroimidazole.

Authors:  Agnik Pal; Sukanta Sen; Suvajit Das; Arunava Biswas; Santanu K Tripathi
Journal:  Iran J Med Sci       Date:  2014-11

4.  Fixed drug eruptions caused by cross-reactive quinolones.

Authors:  P Deepa Kameswari; Nitya Selvaraj; Mangaiarkkarasi Adhimoolam
Journal:  J Basic Clin Pharm       Date:  2014-03

5.  Cefotaxime induced generalized bullous fixed drug eruption - A case report.

Authors:  R Manikandan; A Porselvi; G C Keerthana; K Vaishnavi; S Girija; Murali Narasimhan; T M Vijayakumar
Journal:  Toxicol Rep       Date:  2018-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.